A snapshot of the cardiology measures and codes for the 2007 Medicare Physcian Quality Reporting Initiative

Why This Topic Matters

Cardiology practices participating in quality reporting need to recognize which measures are covered and where the associated diagnosis and procedure code groupings appear. A concise map of the measures and code categories helps support accurate review of the full premium guidance.

Article Sections

1. Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) (Measure #5)

   Introduces a heart failure quality measure and the related coding categories referenced for reporting. The section groups the measure with its associated diagnosis and procedure code listings.

2. CAD: Oral Antiplatelet Therapy prescribed for patients with Coronary Artery Disease (Measure #6)

   Covers a coronary artery disease quality measure and the related code categories used in the reporting table. The section presents the measure alongside diagnosis and procedure code groupings.

3. CAD: Beta-blocker Therapy for Coronary Artery Disease Patients with prior Myocardial Infarction (MI) (Measure #7)

   Summarizes another coronary artery disease measure focused on post-myocardial infarction care. The section lists the accompanying code categories included in the source table.

4. Heart Failure: Beta-blocker therapy for left ventricular systolic dysfunction (Measure #8)

   Covers a second heart failure quality measure and its related reporting code categories. The section mirrors the structure of the source table for this measure.